Biontech-pfizer Vaccine
- All
- News
- Videos
-
No Need Yet To Adapt Pfizer Vaccine For Covid Variants: BioNTech Chief
The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech said Monday.
-
Germany Recommends Vaccine Switch After AstraZeneca First Shot
Germany's vaccine committee on Thursday recommended that everyone who received an AstraZeneca first dose switch to BioNTech-Pfizer or Moderna jabs for better protection against the coronavirus, including against the Delta variant.
-
BioNTech Says 'No Evidence' Its Jabs Need Adapting For COVID-19 Variants
German firm BioNTech said Monday that the Covid-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
-
"Confident" Pfizer Shot Works Against Indian Variant: BioNTech Co-Founder
BioNTech co-founder Ugur Sahin on Wednesday voiced confidence that the vaccine that his company jointly developed with Pfizer works against the Indian variant of the coronavirus.
-
BioNTech-Pfizer Say Covid Vaccine 100% Effective On 12-15 Year Olds
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.
-
BioNTech-Pfizer Pledges 75 Million More Vaccine Doses To European Union
BioNTech and Pfizer said Monday they will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring.
-
European Union Doubles BioNTech-Pfizer Vaccine Order To 600 Million Doses
The EU has struck a deal to double its supply of the BioNTech/Pfizer vaccine against Covid-19 to a total of 600 million doses, European Commission chief Ursula von der Leyen said on Friday.
-
"UK Marks A Historic Moment In Fight Against Covid-19": Pfizer CEO
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
-
No Need Yet To Adapt Pfizer Vaccine For Covid Variants: BioNTech Chief
The first generation vaccine developed by BioNTech-Pfizer works against coronavirus variants such as the Delta strain and does not need to be modified for the moment, the chief executive of German company BioNTech said Monday.
-
Germany Recommends Vaccine Switch After AstraZeneca First Shot
Germany's vaccine committee on Thursday recommended that everyone who received an AstraZeneca first dose switch to BioNTech-Pfizer or Moderna jabs for better protection against the coronavirus, including against the Delta variant.
-
BioNTech Says 'No Evidence' Its Jabs Need Adapting For COVID-19 Variants
German firm BioNTech said Monday that the Covid-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
-
"Confident" Pfizer Shot Works Against Indian Variant: BioNTech Co-Founder
BioNTech co-founder Ugur Sahin on Wednesday voiced confidence that the vaccine that his company jointly developed with Pfizer works against the Indian variant of the coronavirus.
-
BioNTech-Pfizer Say Covid Vaccine 100% Effective On 12-15 Year Olds
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year.
-
BioNTech-Pfizer Pledges 75 Million More Vaccine Doses To European Union
BioNTech and Pfizer said Monday they will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring.
-
European Union Doubles BioNTech-Pfizer Vaccine Order To 600 Million Doses
The EU has struck a deal to double its supply of the BioNTech/Pfizer vaccine against Covid-19 to a total of 600 million doses, European Commission chief Ursula von der Leyen said on Friday.
-
"UK Marks A Historic Moment In Fight Against Covid-19": Pfizer CEO
Britain's approval of BioNTech-Pfizer's vaccine against Covid-19 marks a "historic moment" in the battle against the pandemic, the US pharma group's chief executive said Wednesday, after his company won the first such authorisation in the West.
